CoChat

Long‐term outcome of insulin pump therapy: reduction of hypoglycaemia and impact on glycaemic control

Quirós, C., Giménez, M., Ríos, P., Careaga, M., Roca, D., Vidal, M., Conget, I. · 2016 · Diabetic Medicine
Cited by 40

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Abstract

Aims: To determine the long‐term outcome of continuous subcutaneous insulin infusion (CSII) in Type 1 diabetes according to Catalan National Health Service indications. Methods: Retrospective observational study including 178 patients with Type 1 diabetes who started CSII treatment in our centre (2003–2008). All patients were followed in our CSII programme for outpatients for at least 5 years. Data on annual HbA 1c levels were collected, and the main indication for starting CSII was analysed. Results: Twenty‐seven of 178 patients were excluded because of loss to follow‐up or withdrawal from CSII, thus 151 patients (aged 37.4 ± 10.5 years, 64% women) were analysed. The main indications for starting CSII were suboptimal metabolic control (60.9%), severe hypoglycaemia/hypoglycaemia unawareness (25.5%) and others (13.6%). HbA 1c was 64 ± 13 mmol/mol (8.0 ± 1.2%) at the start of CSII and 62 ± 13 mmol/mol (7.8 ± 1.2%) after 5 years in the total cohort (P = 0.1). The severe hypoglycaemia rates were 0.66 ± 1.61 and 0.17 ± 0.42 episodes/patient/year (P < 0.001). In patients with suboptimal metabolic control, HbA 1c decreased from 68 ± 12 mmol/mol (8.4 ± 1.1%) to 64 ± 14 mmol/mol (8.0 ± 1.3%) (P = 0.016), with 37.4% of those in this group having an HbA 1c ≤ 58 mmol/mol (7.5%) after 5 years. In patients starting CSII due to severe hypoglycaemia the problem was considered resolved in 93%, and in 64% of those starting CSII because of suboptimal glycaemic control, HbA 1c improved significantly. Conclusions: CSII therapy achieves and maintains its efficacy mainly in terms of reducing severe hypoglycaemia. In the whole group of patients, the reduction in HbA 1c is transient and disappears after 5 years.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/dme.13094

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Cited by

See all 40

Metadata

Authors
Quirós, C., Giménez, M., Ríos, P., Careaga, M., Roca, D., Vidal, M., & Conget, I.
Venue
Diabetic Medicine
Publisher
Wiley
Published
2016-04-28
Volume
33
Issue
10
Pages
1422-1426
ISSN
  • 0742-3071 (ISSN-L)
  • 1464-5491
OpenAlex
W2271521534
Cited by
40
References
3
FWCI
7.50
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Long‐term outcome of insulin pump therapy: reduction of hypoglycaemia and impact on glycaemic control. https://app.cochat.ai/papers/10.1111/dme.13094
The paper
Quirós, C., Giménez, M., Ríos, P., Careaga, M., Roca, D., Vidal, M., & Conget, I. (2016). Long‐term outcome of insulin pump therapy: reduction of hypoglycaemia and impact on glycaemic control. Diabetic Medicine. https://doi.org/10.1111/dme.13094

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.